Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 2
1999 2
2000 1
2001 2
2002 1
2004 4
2005 2
2006 1
2007 4
2008 8
2009 11
2010 8
2011 8
2012 11
2013 5
2014 8
2015 7
2016 12
2017 6
2018 11
2019 10
2020 9
2021 13
2022 8
2023 9
2024 10
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Hydroxyurea: how much is enough?
Quinn CT. Quinn CT. Blood. 2023 Feb 23;141(8):813-814. doi: 10.1182/blood.2022018790. Blood. 2023. PMID: 36821183 Free article. No abstract available.
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
Hanna GJ, Villa A, Nandi SP, Shi R, ONeill A, Liu M, Quinn CT, Treister NS, Sroussi HY, Vacharotayangul P, Goguen LA, Annino DJ Jr, Rettig EM, Jo VY, Wong KS, Lizotte P, Paweletz CP, Uppaluri R, Haddad RI, Cohen EEW, Alexandrov LB, William WN Jr, Lippman SM, Woo SB. Hanna GJ, et al. Among authors: quinn ct. JAMA Oncol. 2024 Jan 1;10(1):32-41. doi: 10.1001/jamaoncol.2023.4853. JAMA Oncol. 2024. PMID: 37971722 Free PMC article.
Reproductive equity: preserve the reserve.
Quinn CT, Ware RE. Quinn CT, et al. Blood. 2022 Feb 17;139(7):963-965. doi: 10.1182/blood.2021015021. Blood. 2022. PMID: 35175326 Free article. No abstract available.
The Authors Reply.
Niss O, Quinn CT, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD. Niss O, et al. Among authors: quinn ct. JACC Cardiovasc Imaging. 2016 Sep;9(9):1123-1124. doi: 10.1016/j.jcmg.2016.05.010. JACC Cardiovasc Imaging. 2016. PMID: 27609153 Free article. No abstract available.
Increased oxygen affinity: to have and to hold.
Quinn CT, Ware RE. Quinn CT, et al. Blood. 2021 Sep 30;138(13):1094-1095. doi: 10.1182/blood.2021013243. Blood. 2021. PMID: 34591098 Free article. No abstract available.
Sickle cell disease.
Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH. Buchanan GR, et al. Among authors: quinn ct. Hematology Am Soc Hematol Educ Program. 2004:35-47. doi: 10.1182/asheducation-2004.1.35. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561675 Review.
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL 3rd, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT. Casella JF, et al. Among authors: quinn ct. JAMA. 2021 Apr 20;325(15):1513-1523. doi: 10.1001/jama.2021.3414. JAMA. 2021. PMID: 33877274 Free PMC article. Clinical Trial.
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.
Hanna GJ, O'Neill A, Shin KY, Wong K, Jo VY, Quinn CT, Cutler JM, Flynn M, Lizotte PH, Annino DJ Jr, Goguen LA, Kass JI, Rettig EM, Sethi RKV, Lorch JH, Schoenfeld JD, Margalit DN, Tishler RB, Everett PC, Desai AM, Cavanaugh ME, Paweletz CP, Egloff AM, Uppaluri R, Haddad RI. Hanna GJ, et al. Among authors: quinn ct. Clin Cancer Res. 2022 Feb 1;28(3):468-478. doi: 10.1158/1078-0432.CCR-21-2635. Epub 2021 Oct 19. Clin Cancer Res. 2022. PMID: 34667025 Free PMC article. Clinical Trial.
Hereditary xerocytosis: Diagnostic considerations.
Risinger M, Glogowska E, Chonat S, Zhang K, Dagaonkar N, Joiner CH, Quinn CT, Kalfa TA, Gallagher PG. Risinger M, et al. Among authors: quinn ct. Am J Hematol. 2018 Mar;93(3):E67-E69. doi: 10.1002/ajh.24996. Epub 2017 Dec 23. Am J Hematol. 2018. PMID: 29210095 Free PMC article. No abstract available.
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.
Grimley M, Davies SM, Shrestha A, Shova A, Asnani M, Kent M, Sayani F, Quinn CT, Niss O, Lutzko C, Mehta PA, Khandelwal P, Little C, Chandra S, Felker S, Chi M, Kalfa TA, Knight-Madden J, Arumugam PI, Ramos KN, Witting S, Latham T, Bushman FD, Malik P. Grimley M, et al. Among authors: quinn ct. Nat Med. 2025 Jul;31(7):2204-2212. doi: 10.1038/s41591-025-03662-2. Epub 2025 May 26. Nat Med. 2025. PMID: 40419809 Clinical Trial.
166 results